0 0 01/04/2024 31/03/2025 2025-03-31 false false false false false false true true false false true false false false false false true false No description of principal activities is disclosed 2024-04-01 Sage Accounts Production 24.0 - FRS102_2024 xbrli:pure xbrli:shares iso4217:GBP 15605869 2024-04-01 2025-03-31 15605869 2025-03-31 15605869 2024-03-31 15605869 bus:Director2 2024-04-01 2025-03-31 15605869 core:ShareCapital 2024-04-01 2025-03-31 15605869 core:ShareCapital 2025-03-31 15605869 core:PreviouslyStatedAmount core:ShareCapital 2025-03-31 15605869 bus:SmallEntities 2024-04-01 2025-03-31 15605869 bus:AuditExempt-NoAccountantsReport 2024-04-01 2025-03-31 15605869 bus:SmallCompaniesRegimeForAccounts 2024-04-01 2025-03-31 15605869 bus:EntityHasNeverTraded 2024-04-01 2025-03-31 15605869 bus:PrivateLimitedCompanyLtd 2024-04-01 2025-03-31 15605869 bus:FullAccounts 2024-04-01 2025-03-31
Company registration number: 15605869
Associated Protein Limited
Unaudited filleted financial statements
31 March 2025
Associated Protein Limited
Contents
Statement of financial position
Statement of changes in equity
Notes to the financial statements
Associated Protein Limited
Statement of financial position
31 March 2025
2025
Note £ £
Current assets
Debtors 4 1
_______
Net current assets 1
_______
Total assets less current liabilities 1
_______
Net assets 1
_______
Capital and reserves
Called up share capital 1
_______
Shareholders funds 1
_______
The company did not trade during the current year or prior year and has not made either a profit or loss.
For the year ending 31 March 2025 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.
Directors responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements.
These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies' regime and in accordance with Section 1A of FRS 102 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
In accordance with section 444 of the Companies Act 2006, the statement of comprehensive income has not been delivered.
These financial statements were approved by the board of directors and authorised for issue on 31 December 2025 , and are signed on behalf of the board by:
Mr T Rudgley
Director
Company registration number: 15605869
Associated Protein Limited
Statement of changes in equity
Year ended 31 March 2025
Called up share capital Total
£ £
At 1 April 2024 - -
Profit for the year -
_______ _______
Total comprehensive income for the year - -
Issue of shares 1 1
_______ _______
Total investments by and distributions to owners 1 1
_______ _______
At 31 March 2025 1 1
_______ _______
Associated Protein Limited
Notes to the financial statements
Year ended 31 March 2025
1. General information
The company is a private company limited by shares, registered in England & Wales. The address of the registered office is Asco House, Helions Bumpstead Road, Haverhill, Suffolk, CB9 7AA.
2. Statement of compliance
These financial statements have been prepared in compliance with the provisions of FRS 102, Section 1A, 'The Financial Reporting Standard applicable in the UK and Republic of Ireland'.
3. Accounting policies
Basis of preparation
The financial statements have been prepared on the historical cost basis. The financial statements are prepared in sterling, which is the functional currency of the entity.
Income statement policy
The company is dormant as defined by section 1169 of the Companies Act 2006. The company received no income and incurred no expenditure during the current year.
Taxation
The taxation expense represents the aggregate amount of current and deferred tax recognised in the reporting period. Current tax is recognised on taxable profit for the current and past periods. Current tax is measured at the amounts of tax expected to pay or recover using the tax rates and laws that have been enacted or substantively enacted at the reporting date. Deferred tax is recognised in respect of all timing differences at the reporting date. Deferred tax is measured using the tax rates and laws that have been enacted or substantively enacted by the reporting date that are expected to apply to the reversal of the timing difference.
Financial instruments
A financial asset or a financial liability is recognised only when the company becomes a party to the contractual provisions of the instrument.Basic financial instruments are initially recognised at the transaction price, unless the arrangement constitutes a financing transaction, where it is recognised at the present value of the future payments discounted at a market rate of interest for a similar debt instrument.Debt instruments are subsequently measured at amortised cost.
4. Debtors
2025
£
Other debtors 1
_______